The association between marijuana smoking and lung cancer: A systematic review

Archives of Internal Medicine

Volumn 166, Issue 13, 2006, Pages 1359-1367

  Mehra, Reena ^a,d   Moore, Brent A ^c   Crothers, Kristina ^c   Tetrault, Jeanette ^b,c   Fiellin, David A ^c  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

^c YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; TAR;

ADULT; AGED; ANTINEOPLASTIC ACTIVITY; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CANCER INCIDENCE; CANCER RISK; CARCINOGENESIS; CELL STRUCTURE; CONTROLLED STUDY; DATA BASE; DISEASE COURSE; EMBASE; EPIDEMIOLOGY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG ALVEOLUS MACROPHAGE; LUNG CANCER; MAJOR CLINICAL STUDY; MALE; MEDLINE; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PRIORITY JOURNAL; PSYCINFO; QUALITY CONTROL; REVIEW; SAMPLE SIZE; SMOKING; SPUTUM ANALYSIS; SYSTEMATIC REVIEW; TOBACCO;

HUMANS; HYPERPLASIA; KI-67 ANTIGEN; LUNG; LUNG NEOPLASMS; MARIJUANA SMOKING; RECEPTOR, EPIDERMAL GROWTH FACTOR; RESEARCH DESIGN; TARS;

EID: 33745828362     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.166.13.1359     Document Type: Review

References (46)

1. Substance Abuse and Mental Health Services Administration. Results From the 2003 National Survey on Drug Use and Health: National Findings. Rockville, Md: SAMHSA; 2004. National Survey on Drug Use and Health Series H-25. DHHS publication (SMA) 04-3964.
2. National Cancer Institute. Cancer Progress Report 2003. http://progressreport.cancer.gov/doc.asp?pid=1&did=21&chid=13&coid= 33&mid=vpco. Accessed September 12, 2005.
3. Compton WM, Grant BF, Colliver JD, Glantz MD, Stinson FS. 2004. Prevalence of marijuana use disorders in the United States: 1991-1992 and 2001-2002. JAMA. 2004;291:2114-2121.
4. Denissenko MF, Pao A, Tang M, Pfeifer GP. Preferential formation of benzo[a]pyrene adducts at lung cancer mutational hotspots in P53. Science. 1996;274:430-432.
5. Hoffman D, Brunnemann KD, Gori GB, et al. On the carcinogenicity of marijuana smoke. In: Runeckles VC, ed. Recent Advances in Phytochemistry. New York, NY: Plenum;1975: 63-81.
6. Novotny M, Merli F, Weisler D, Fencl M, Saeed T. Fractionation and capillary gas chromatographic mass spectrometric characterization of the neutral components in marijuana and tobacco smoke concentrates. J Chromatogr. 1982;238:141-150.
7. Tashkin DP. Smoked marijuana as a cause of lung injury. Monaldi Arch Chest Dis. 2005;63:93-100.
8. Galve-Roperh I, Sanchez C, Cortes ML, del Pulgar TG, Izquierdo M, Guzman M. Anti-tumoral action of cannabinoids: involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nat Med. 2000;6:313-319.
9. Hart S, Fischer OM, Ullrich A. Cannabinoids induce cancer cell proliferation via tumor necrosis factor alpha-converting enzyme (TACE/ADAM17)-mediated transactivation of the epidermal growth factor receptor. Cancer Res. 2004;64:1943-1950.
10. Zhu LX, Sharma S, Stolina M, et al. Delta-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J Immunol. 2000;165:373-380.
11. Kogan NM. Cannabinoids and cancer. Mini Rev Med Chem. 2005;5:941-952.
12. Melamede R. Cannabis and tobacco smoke are not equally carcinogenic. Harm Reduct J. 2005;2:21.
13. Munson AE, Harris LS, Friedman MA, Dewey WL, Carchman RA. Antineoplastic activity of cannabinoids. J Natl Cancer Inst. 1975;55:597-602.
14. Downs SH, Black N. The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions. J Epidemiol Community Health. 1998;52:377-384.
15. Matthias P, Tashkin DP, Marques-Magallanes JA, Wilkins JN, Simmons MS. Effects of varying marijuana potency on deposition of tar and delta9-THC in the lung during smoking. Pharmacol Biochem Behav. 1997;58:1145-1150.
16. Tashkin DP, Gliederer F, Rose J, et al. Tar, CO and Delta9THC delivery from the 1st and 2nd halves of a marijuana cigarette. Pharmacol Biochem Behav. 1991;40:657-661.
17. Tashkin DP, Gliederer F, Rose J, et al. Effects of varying marijuana smoking profile on deposition of tar and absorption of CO and delta-9-THC. Pharmacol Biochem Behav. 1991;40:651-656.
18. Wu TC, Tashkin DP, Djahed B, Rose JE. Pulmonary hazards of smoking marijuana as compared with tobacco. N Engl J Med. 1988;318:347-351.
19. Baldwin GC, Tashkin DP, Buckley DM, Park AN, Dubinett SM, Roth MD. Marijuana and cocaine impair alveolar macrophage function and cytokine production. Am J Respir Crit Care Med. 1997;156:1606-1613.
20. Barsky SH, Roth MD, Kleerup EC, Simmons M, Tashkin DP. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J Natl Cancer Inst. 1998;90:1198-1205.
21. Fligiel SE, Roth MD, Kleerup EC, Barsky SH, Simmons MS, Tashkin DP. Tracheobronchial histopathology in habitual smokers of cocaine, marijuana, and/or tobacco. Chest. 1997;112:319-326.
22. Fligiel SE, Venkat H, Gong H Jr, Tashkin DP. Bronchial pathology in chronic marijuana smokers: a light and electron microscopic study. J Psychoactive Drugs. 1988;20:33-42.
23. Gong H Jr, Fligiel S, Tashkin DP, Barbers RG. Tracheobronchial changes in habitual, heavy smokers of marijuana with and without tobacco. Am Rev Respir Dis. 1987;136:142-149.
24. Sasco AJ, Merrill RM, Dari I, et al. A case-control study of lung cancer in Casablanca, Morocco. Cancer Causes Control. 2002;13:609-616.
25. Sidney S, Quesenberry CP Jr, Friedman GD, Tekawa IS. Marijuana use and cancer incidence (California, United States). Cancer Causes Control. 1997;8:722-728.
26. Starr K, Renneker M. A cytologic evaluation of sputum in marijuana smokers. J Fam Pract. 1994;39:359-363.
27. Roby TJ, Hubbard G, Swan GE. Cytomorphologic features of sputum samples from marijuana smokers. Diagn Cytopathol. 1991;7:229-234.
28. Sarafian TA, Tashkin DP, Roth MD. Marijuana smoke and Delta(9)-tetrahydrocannabinol promote necrotic cell death but inhibit Fas-mediated apoptosis. Toxicol Appl Pharmacol. 2001;174:264-272.
29. Sherman MP, Aeberhard EE, Wong VZ, Simmons MS, Roth MD, Tashkin DP. Effects of smoking marijuana, tobacco or cocaine alone or in combination on DNA damage in human alveolar macrophages. Life Sci. 1995;56:2201-2207.
30. Tennant FS Jr. Histopathologic and clinical abnormalities of the respiratory system in chronic hashish smokers. Subst Alcohol Actions Misuse. 1980;1:93-100.
31. Sridhar KS, Raub WA Jr, Weatherby NL, et al. Possible role of marijuana smoking as a carcinogen in the development of lung cancer at a young age. J Psychoactive Drugs. 1994;26:285-288.
32. Taylor FM III. Marijuana as a potential respiratory tract carcinogen: a retrospective analysis of a community hospital population. South Med J. 1988;81:1213-1216.
33. Henderson RL, Tennant FS, Guerry R. Respiratory manifestations of hashish smoking. Arch Otolaryngol. 1972;95:248-251.
34. Sarafian TA, Magallanes JA, Shau H, Tashkin D, Roth MD. Oxidative stress produced by marijuana smoke: an adverse effect enhanced by cannabinoids. Am J Respir Cell Mol Biol. 1999;20:1286-1293.
35. Kaufman DW, Palmer JR, Rosenberg L, Stolley P, Warshauer E, Shapiro S. Tar content of cigarettes in relation to lung cancer. Am J Epidemiol. 1989;129:703-711.
36. Yoshie Y, Ohshima H. Synergistic induction of DNA strand breakage by cigarette tar and nitric oxide. Carcinogenesis. 1997;18:1359-1363.
37. Zang EA, Wynder EL. Cumulative tar exposure: a new index for estimating lung cancer risk among cigarette smokers. Cancer. 1992;70:69-76.
38. An Y, Kato K, Nakano M, Otsu H, Okada S, Yamanaka K. Specific induction of oxidative stress in terminal bronchiolar Clara cells during dimethylarsenic-induced lung tumor promoting process in mice. Cancer Lett. 2005;230:57-64.
39. Kaynar H, Meral M, Turhan H, Keles M, Celik G, Akcay F. Glutathione peroxidase, glutathione-S-transferase, catalase, xanthine oxidase, Cu-Zn superoxide dismutase activities, total glutathione, nitric oxide, and malondialdehyde levels in erythrocytes of patients with small cell and non-small cell lung cancer. Cancer Lett. 2005;227:133-139.
40. Masri FA, Comhair SA, Koeck T, et al. Abnormalities in nitric oxide and its derivatives in lung cancer. Am J Respir Crit Care Med. 2005;172:597-605.
41. Stringer B, Kobzik L. Environmental particulat-emediated cytokine production in lung epithelial cells (A549): role of preexisting inflammation and oxidant stress. J Toxicol Environ Health A. 1998;55:31-44.
42. Ammenheuser MM, Berenson AB, Babiak AE, Singleton CR, Whorton EB Jr. Frequencies of hprt mutant lymphocytes in marijuana-smoking mothers and their newborns. Mutat Res. 1998;403:55-64.
43. Roth MD, Marques-Magallanes JA, Yuan M, Sun W, Tashkin DP, Hankinson O. Induction and regulation of the carcinogen-metabolizing enzyme CYP1A1 by marijuana smoke and delta (9)-tetrahydrocannabinol. Am J Respir Cell Mol Biol. 2001;24:339-344.
44. Sarafian TA, Kouyoumjian S, Khoshaghideh F, Tashkin DP, Roth MD. Delta 9-tetrahydrocannabinol disrupts mitochondrial function and cell energetics. Am J Physiol Lung Cell Mol Physiol. 2003;284:L298-L306.
45. Morgenstern HM. Marijuana use and the risks of lung and other cancers. National Institute of Drug Abuse on Computer Retrieval of Information on Scientific Projects Web site. http://crisp.cit.nih.gov/crisp/CRISP_LIB.getdoc? textkey=2761718&p_grant_num=1R01DA01138601A1&p_query=&ticket= 20721777&p_audit_session_id=92963459&p_keywords=. Accessed February 20, 2006.
46. Tashkin DP, Zhang ZF, Greenland S, Cozen W, Mack TM, Morgenstern H. Marijuana use and lung cancer: results of a case-control study. American Thoracic Society web site. http://www.abstracts2view.com/ats06/. Accessed May 30, 2006.